Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner

ByJohn Garica

Award celebrates bold leaders shaping the future through the world’s most ground-breaking companies. Source: BioStem Technologies, Inc. POMPANO BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) — Ernst & Young LLP (EY…

BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

ByJohn Garica

POMPANO BEACH, Fla., May 29, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care,…

Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist

ByJohn Garica

May 22, 2025Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future POMPANO BEACH, Fla., May 22, 2025 (GLOBE NEWSWIRE) —BioStem Technologies, Inc.(OTC: BSEM) (the “Company” or “BioStem”),…

BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting

ByJohn Garica

May 01, 2025 07:00 ET | Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management. Three accepted scientific posters will feature BioStem’s advanced…

BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million

ByJohn Garica

POMPANO BEACH, Fla., April 14, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacture, and commercialization of…